Skip to main content
. 2019 Nov 6;2019:4267357. doi: 10.1155/2019/4267357

Figure 5.

Figure 5

Typical case of the Bahrain study. HbA1c in the patient under long-term therapy with high/maximum doses of oral hypoglycemic agents was dramatically improved by 5-ALA/SFC supplement (HbA1c decreased from 8.6 to 6.1 in 12 weeks) (unpublished data).